KSM-66® vs Shoden® vs Sensoril®: Which Ashwagandha Extract Is Right for You?
Three patented ashwagandha extracts dominate the clinical research. Each was tested at a different dose, on a different part of the plant, for different outcomes. Here’s how to read the spec sheet and pick the form that matches what you actually need.
Quick answer: KSM-66®, Sensoril®, and Shoden® are three patented, standardized ashwagandha extracts — not interchangeable. KSM-66® uses the root only, is standardized to 5% withanolides, and has the deepest clinical-trial library at 600mg/day. Optibio Ashwagandha KSM-66® uses the same KSM-66® extract at the dose the studies tested.†
If you’ve compared more than two ashwagandha bottles, you’ve seen this: same plant, three different patented forms, three different dose ranges, and product copy that talks past the question. KSM-66®, Sensoril®, and Shoden® are not marketing labels — they’re distinct extracts with distinct clinical trials behind them. Which one fits depends on what you’re actually trying to support: stress, sleep, cognition, endurance, or general resilience.
Below is the cleanest side-by-side breakdown of all three. We pull the dose, the part of the plant, the standardization percentage, the headline trial each extract was tested in, and a plain-language read on who each extract is best suited for.
What makes a patented ashwagandha extract different
Generic ashwagandha root or leaf powder has no controlled withanolide content — the active compounds can vary 1–4% batch to batch. A patented extract guarantees three things:
Standardization
The percentage of withanolides (the active compounds) in the extract is verified and consistent across batches.
Identified plant part
Root only, leaf and root, or aerial parts — clinical evidence depends on which part was tested in the trial.
Clinical-trial dose anchor
Each extract has a specific dose used in its peer-reviewed trials. Stray from that dose and the published outcomes don’t apply.
That’s why KSM-66®, Sensoril®, and Shoden® are not directly substitutable on a milligram basis. The 600mg of KSM-66® used in Chandrasekhar 2012 is not equivalent to 600mg of Sensoril® or 600mg of Shoden®. They were tested at different doses for different outcomes.
KSM-66®: the most-studied form
Source: Patented by Ixoreal Biomed. Released 2009. Uses ashwagandha root only, with a 14-day proprietary milk-based extraction that preserves the full-spectrum withanolide profile of the root.
Standardization: 5% withanolides minimum (verified per batch).
Clinical-trial dose: 600mg/day, taken as 300mg twice daily or 600mg once daily.
Headline trials:
- Chandrasekhar 2012 — 600mg/day for 60 days reduced serum cortisol by 27.9% in chronically stressed adults.
- Langade 2019 — 600mg/day for 10 weeks improved sleep efficiency from 75.6% to 83.5%.
- Choudhary 2015 — 600mg/day for 8 weeks increased VO2max by 13.6% vs 4.4% in placebo (P<0.0001) in athletic adults.
- Choudhary 2017 — 600mg/day for 8 weeks improved memory, executive function, and attention in adults with mild cognitive impairment.
- Wankhede 2015 — 600mg/day for 8 weeks improved muscle strength, recovery, and lean mass in healthy young men.
Best for: Anyone who wants the deepest, broadest peer-reviewed evidence library. KSM-66® is the form referenced in the majority of mainstream press coverage and clinician recommendations for ashwagandha. Optibio® Ashwagandha KSM-66® uses 600mg per serving — the exact clinical dose.†
Sensoril®: a leaf-and-root extract at lower doses
Source: Patented by Natreon. Uses both ashwagandha leaves and roots. Different extraction process from KSM-66® — concentrates a higher percentage of withanolides per gram of extract.
Standardization: 8–10% withanolides (higher concentration than KSM-66®).
Clinical-trial dose: 125–250mg/day. Note the dose is roughly half to a third of what KSM-66® trials used.
Headline trial: Auddy 2008 tested 250mg/day Sensoril® for 60 days in chronically stressed adults — reductions in cortisol, perceived stress, and a marker of oxidative stress.
Best for: People specifically directed by a clinician toward Sensoril®, or those who prefer a leaf-and-root extract at a lower mg dose. The total milligrams of withanolides delivered at 250mg Sensoril® (~22mg withanolides) is similar to 600mg KSM-66® (~30mg withanolides), so they’re not as far apart on active-compound delivery as the dose numbers suggest.
Shoden®: the newest, lowest-dose form
Source: Patented by Arjuna Natural. Uses ashwagandha leaves and roots. Concentrates withanolide glycosides at a much higher percentage than KSM-66® or Sensoril®.
Standardization: 35% withanolide glycosides (the most concentrated of the three).
Clinical-trial dose: 120mg/day. Much smaller capsule, much smaller mg total.
Headline trial: Salve 2019 and a smaller body of subsequent trials at 120mg/day for stress, sleep, and serum cortisol.
Best for: Someone who wants the smallest possible capsule size or who has trouble swallowing larger pills. The trade-off is a smaller, newer evidence base relative to KSM-66®.
Side-by-side comparison
| Extract | Plant part | Standardization | Clinical dose | Trials | Best for |
|---|---|---|---|---|---|
| KSM-66® | Root only | 5% withanolides | 600mg/day | 22+ peer-reviewed | Broadest evidence; stress, sleep, cognition, endurance |
| Sensoril® | Leaf + root | 8–10% withanolides | 125–250mg/day | Smaller library | Lower-dose option, clinician-directed protocols |
| Shoden® | Leaf + root | 35% withanolide glycosides | 120mg/day | Newest, smallest library | Smaller capsule preference |
Which extract is right for you?
The decision usually comes down to two questions:
1. What outcome are you trying to support?
- Stress and cortisol — KSM-66® has the largest peer-reviewed library here, anchored by the Chandrasekhar 2012 cortisol-reduction finding.
- Sleep quality — KSM-66® is the form tested in the Langade 2019 sleep-efficiency trial.
- Cognitive performance — KSM-66® at 600mg/day has been studied in adults with mild cognitive impairment (Choudhary 2017).
- Athletic performance / VO2max — KSM-66® is the only form with a published 13.6% VO2max increase trial (Choudhary 2015).
- Strength & recovery — KSM-66® at 600mg/day improved muscle strength and lean mass in Wankhede 2015.
2. Are you replicating a published clinical trial — or trying something for the first time?
- If you want to match published outcomes precisely, use the form tested in the trial at the exact dose. For most outcomes that points to KSM-66® at 600mg/day.
- If you have a clinician recommendation for Sensoril® or Shoden®, follow that recommendation — those extracts have their own evidence base and may suit specific protocols.
A note on generic ashwagandha
Generic ashwagandha root or leaf powder is not equivalent to any of these three patented extracts. Without standardization, withanolide content varies 1–4% from batch to batch. Generic ashwagandha at 600mg might deliver one-third the active withanolides of standardized KSM-66® at the same milligram count — or roughly equivalent — depending on the batch. None of the published trials use unstandardized generic powder, so you can’t reliably replicate published outcomes with it.
If price is the only constraint, generic ashwagandha is a reasonable starting point to see whether ashwagandha agrees with you at all. If clinical-trial outcomes are the goal, a patented extract at the trial dose is what the research supports.
Frequently asked questions
Is KSM-66® better than Sensoril®?
“Better” depends on the outcome you’re targeting. KSM-66® has more peer-reviewed trials across more outcome categories — stress, sleep, cognition, endurance, strength. Sensoril® has its own evidence at a lower dose. For most consumer health goals where ashwagandha is recommended, KSM-66® is the more-studied option.
Is KSM-66® better than regular ashwagandha?
For evidence-based daily use, yes. KSM-66® is standardized (consistent withanolide content batch to batch) and root-only (the part used in clinical trials). Generic ashwagandha varies in withanolide content and often uses leaf or aerial parts of the plant. If you want to replicate published research, KSM-66® is the closer match.
What does “5% withanolides” mean?
Withanolides are the active compounds in ashwagandha. KSM-66® is standardized to a minimum of 5% withanolides, meaning every batch is verified to contain at least that concentration of active compounds. Without standardization, those numbers swing batch to batch and you can’t replicate the dose used in trials.
Can I take Sensoril® at the KSM-66® dose (600mg)?
Sensoril® at 600mg has not been studied for safety in the published literature. The trials use 125–250mg/day. If you want a 600mg ashwagandha dose, the research-supported option is KSM-66®.
Is Shoden® just a smaller dose of the same thing?
No. Shoden® is a different extract with a different concentration profile (35% withanolide glycosides) and uses leaf and root, not root only. The 120mg dose is small because the extract is more concentrated, but the underlying material is different from KSM-66®.
Which extract has the most clinical research?
KSM-66® has the largest peer-reviewed trial library — 22+ human studies covering stress, sleep, cognition, endurance, strength, and testosterone outcomes. Sensoril® and Shoden® have smaller, more recent libraries.
How do I know which extract is in a supplement I’m considering?
Look for the extract name on the label or supplement facts: “KSM-66®”, “Sensoril®”, or “Shoden®”. If a product just says “ashwagandha extract” without a patented form, it’s likely generic and not equivalent to any of the three.
Does Optibio® use KSM-66®?
Yes. Optibio® Ashwagandha uses KSM-66® at 600mg per serving — the exact dose used in the Chandrasekhar 2012, Langade 2019, Choudhary 2015, and Choudhary 2017 trials. You can review the underlying clinical evidence on our science page.
The bottom line
For most people researching ashwagandha for the first time, KSM-66® at 600mg/day is the form with the deepest peer-reviewed library across the outcomes consumers actually care about — stress, sleep, cognition, endurance, and strength. Sensoril® and Shoden® are valid options for specific protocols at lower doses, but their evidence libraries are smaller and more recent.
Optibio® Ashwagandha KSM-66® uses the exact dose tested in the trials — 600mg of KSM-66® per serving. If you want to replicate the outcomes you’ve seen cited in the press, the dose and the extract type both have to match what was tested.† For a side-by-side ranking of the top 8 ashwagandha brands across all formats, see our complete 2026 buyer’s guide.
Shop Optibio Ashwagandha KSM-66® →
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.